X0704 D LIVE 0001545211 Sprout Pharmaceuticals, Inc. 4208 SIX FORKS ROAD SUITE 1010 RALEIGH NC NORTH CAROLINA 27609 919-882-0850 DELAWARE None None Corporation true 2011 Robert S. Whitehead 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Executive Officer Director Director, President and Chief Executive Officer Matthew Petzold 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Executive Officer Chief Financial Officer and Treasurer Fred Pruden 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Executive Officer Vice President, Manufacturing Cynthia Whitehead 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Executive Officer Chief Commercial Officer Douglas Eckert 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Executive Officer Director Director and Secretary W. Robert Dahl 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Director Trygve Mikkelsen 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Director Anthony Wild 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Director Braxton Goodrich 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Director Richard DeSchutter 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Director James Symons 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Executive Officer Vice President, Drug Development Michael Ford 4208 Six Forks Road Suite 1010 Raleigh NC NORTH CAROLINA 27609 Director Pharmaceuticals Decline to Disclose 06 false 2012-03-08 false true false 50000 N/A None None None N/A N/A N/A NC NORTH CAROLINA 27609 AL ALABAMA AZ ARIZONA CA CALIFORNIA CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS KY KENTUCKY MA MASSACHUSETTS NH NEW HAMPSHIRE NY NEW YORK NC NORTH CAROLINA OH OHIO TX TEXAS false 5000000 5000000 0 The Board of Directors of the Issuer may, in its discretion, increase the aggregate offering amount to $6,000,000. false 61 0 0 0 The Proceeds will be used for working capital purposes, of which a portion will be used to pay the salaries of the Issuer's executive officers. false Sprout Pharmaceuticals, Inc. /s/ Matthew Petzold Matthew Petzold Chief Financial Officer 2012-03-21